Key result
Measurement of high-sensitivity C-reactive protein may help guide medical treatment initiation and adjustment in certain groups of subjects for primary and secondary prevention of cardiovascular disease.
Why the study?
Does measurement of hsCRP levels improve risk prediction and guide medical treatment in primary and secondary prevention of cardiovascular disease?
Does measurement of hsCRP levels improve risk prediction and guide medical treatment in primary and secondary prevention of cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Measurement of hsCRP levels may help guide medical treatment initiation and adjustment in certain groups of subjects both in primary and secondary prevention.
Based on evidence that inflammatory processes play a fundamental role in the development of cardiovascular disease, high sensitivity C-reactive protein (hsCRP) is considered a powerful risk marker for cardiovascular events. Irrespective of a potential role in risk prediction, recent evidence implicates a direct involvement of CRP per se in the pathogenesis of atherosclerotic cardiovascular disease. In the present article we review the literature concerning clinical studies assessing the association between hsCRP concentration and cardiovascular disease. Measurement of hsCRP levels may help guiding medical treatment initiation and adjustment in certain groups of subjects both in the primary and secondary prevention.
No takes yet. Share an insight, caveat, or question.
Nakou et al. (2012) conducted a review in Cardiovascular disease. High-sensitivity C-reactive protein (hsCRP) measurement was evaluated. Measurement of high-sensitivity C-reactive protein may help guide medical treatment initiation and adjustment in certain groups of subjects for primary and secondary prevention of cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: